In summary, engineered GLP-1R-targeting nanoplatforms represent a transformative approach in the management of metabolic liver disease, enabling targeted delivery, enhanced pharmacokinetics, and multifunctional therapeutic capabilities that go beyond the limitations of conventional therapies
Stopping treatment can lead to metformin withdrawal symptoms
tirzepatide activates GLP-1 and GIP
Lancet Diabetes Endocrinol
GLP-1 stands for glucagon-like peptide-1 , a hormone that your body naturally releases from the gut after you eat
Using real-world data The study has been published in Nature Health and investigated data from 410,198 Reddit posts by 67,008 users, between May 2019 and June 2025